A carregar...
Population pharmacokinetic analysis of infliximab in patients with ulcerative colitis
PURPOSE: Infliximab, a monoclonal antibody, is approved for the treatment of inflammatory diseases at doses that depend on the patient disease population. It was the aim of this study to evaluate its population pharmacokinetics in patients with moderately to severely active ulcerative colitis and ch...
Na minha lista:
| Formato: | Artigo |
|---|---|
| Idioma: | en |
| Publicado em: |
Springer-Verlag
2009
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2778780/ https://ncbi.nlm.nih.gov/pubmed/19756557 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00228-009-0718-4 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|